SOAT1 and obesity disorder: These effects of baricitinib were associated with a significant reduction in the plasma concentrations of the JAK-STAT dependent cytokines IL-1β, TNF-α, and IFN-γ, whose role in obesity and insulin resistance has been widely documented.